Angelo Cattaneo

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Non-pustular primary annular plaque-type psoriasis.

Non-pustular primary annular plaque-type psoriasis.

Journal: Italian journal of dermatology and venereology

Published: September 09, 2024

Belimumab-induced periungual pyogenic granulomas: A case report.

Belimumab-induced periungual pyogenic granulomas: A case report.

Journal: Lupus

Published: June 11, 2024

Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.

Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence.

Journal: Dermatology and therapy

Published: April 30, 2024

A new instrument for the screening of psoriatic arthritis among psoriatic patients.

A new instrument for the screening of psoriatic arthritis among psoriatic patients.

Journal: Clinical and experimental rheumatology

Published: March 29, 2024

Antinuclear matrix protein 2 antibody-positive dermatomyositis: a rare entity.

Antinuclear matrix protein 2 antibody-positive dermatomyositis: a rare entity.

Journal: Italian journal of dermatology and venereology

Published: January 16, 2024

A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review.

A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review.

Journal: International journal of molecular sciences

Published: November 01, 2023

Telangiectatic Macules Spreading During More Than 30 Years: A Quiz.

Telangiectatic Macules Spreading During More Than 30 Years: A Quiz.

Journal: Acta dermato-venereologica

Published: August 19, 2023

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.

Journal: Clinical, cosmetic and investigational dermatology

Published: May 16, 2023

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Journal: Clinical, cosmetic and investigational dermatology

Published: December 13, 2022

Polymorphic rupioid psoriasis with chamomile-like lesions: A case report.

Polymorphic rupioid psoriasis with chamomile-like lesions: A case report.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 25, 2022

Single-Centre Real-Life Experience of Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis.

Single-Centre Real-Life Experience of Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis.

Journal: Journal of drugs in dermatology : JDD

Published: August 10, 2022

Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter".

Reply to "Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the "minimal disease activity" parameter".

Journal: Dermatologic therapy

Published: May 11, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026